Androgen receptor (AR) mutations in patients (pts) with castration-resistant prostate cancer (CRPC) with and without prior abiraterone acetate (AA) treatment Meeting Abstract


Authors: Rathkopf, D. E.; Smith, M. R.; Antonarakis, E. S.; Ryan, C. J.; Berry, W. R.; Shore, N. D.; Liu, G.; Higano, C.; Alumkal, J. J.; Hauke, R.; Tutrone, R.; Saleh, M.; Maneval, E. C.; Thomas, S.; Ricci, D.; Yu, M. K.; de Boer, C. J.; Trinh, A.; Kheoh, T.; Bandekar, R.; Scher, H. I.
Abstract Title: Androgen receptor (AR) mutations in patients (pts) with castration-resistant prostate cancer (CRPC) with and without prior abiraterone acetate (AA) treatment
Meeting Title: 106th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 75
Issue: 15 Suppl.
Meeting Dates: 2015 Apr 18-22
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2015-08-01
Language: English
ACCESSION: WOS:000371597100030
DOI: 10.1158/1538-7445.am2015-ct134
PROVIDER: wos
Notes: Meeting Abstract: CT134 -- 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 18-22, 2015 -- Philadelphia, PA -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    272 Rathkopf
  2. Howard Scher
    1130 Scher